(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today provided an update on ...

On November 13, Spain's Ministry of Agriculture, Fisheries and Food imposed the confinement of all free-range poultry farms ...

There are strict rules around reporting a whole range of common health complaints affecting millions of people ...

Biohaven Ltd. narrows focus to three late-stage clinical programs and implements cost-cutting to address heavy R&D spending.

Avian influenza virus cases tend to rise during the colder months, as is the case with human influenza. However, since 2020, ...

CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company focused on unlocking ...

Mycoplasma pneumoniae infections have risen significantly post-COVID-19, presenting with both respiratory and increasing non-respiratory symptoms, including dermatologic and neurologic manifestations.

The DVLA has confirmed a list of 118 conditions that all motorists must declare to avoid being penalised. This is the ...

Collaboration Revenues: Voyager had collaboration revenue of $13.4 million for the third quarter of 2025, compared to $24.6 million for the same period in 2024. The decrease was primarily due to ...

Jean-Martin Charcot (1825-1893), the first major international clinical neurologist. In this celebration year, symposia, ...

Investigators who designed a base-editing treatment are planning an "umbrella of umbrellas" trial, while others are developing roadmaps to guide personalized treatments.